The Quarter in Context

A nighttime view of an industrial factory with smokestacks emitting smoke, highlighting energy production and pollution.

Occidental's second-quarter results for the period ended June 30, 2026 reflect a sharp rebound in realized oil prices layered on top of a fundamentally reshaped business. Net sales of $8.07 billion for the quarter more than doubled from a year ago, while net income of $2.996 billion rose roughly sixfold versus Q2 2025. The defining event of the period, however, sits in the prior quarter: the January 2, 2026 closing of the all-cash sale of OxyChem to Berkshire Hathaway for an adjusted $9.5 billion, which produced a $3.1 billion gain and is now reported as discontinued operations.

The operating story is straightforward. Average worldwide realized oil prices jumped to $96.78 per barrel in Q2 2026 from $69.91 per barrel in Q1 2026, and the company lifted oil and gas segment earnings to $2.849 billion from $1.017 billion quarter-over-quarter. Total sales volumes held roughly steady at 1,433 Mboe/d, indicating that price—not volume—drove the swing. Operating cash flow of $4.271 billion for the quarter, combined with $8.695 billion in debt repayments during the first half, demonstrates the conversion of a commodity windfall into balance-sheet repair.

Business Model and Profit Engine

Occidental earns by selling hydrocarbons produced from upstream acreage and by capturing margins on the gathering, processing, transportation, storage and marketing of crude oil, NGL and natural gas. Customers are predominantly commodity wholesalers, refiners and industrial gas buyers; Occidental typically sells oil and gas at the lease or concession area, while the midstream and marketing segment executes sales at the point where it holds title. Revenue is overwhelmingly transactional: there are no multi-year subscription contracts, and prices reset with each barrel or cubic foot delivered.

The revenue stack in Q2 2026 was dominated by oil and gas segment sales of $6.777 billion, with crude oil contributing $6.289 billion and NGL adding $681 million. Gas realizations were negative in the U.S. at ($1.48) per Mcf due to basis and transportation basis differentials, a data point that deserves emphasis because it illustrates how even a large producer can fail to capture economic rent on a portion of its volume. Midstream and marketing contributed $419 million in revenue from customers, but its $1.338 billion of segment earnings indicate that value capture here comes from margin on logistics and trading rather than from volume alone. The operating leverage is therefore substantial: a modest change in the headline WTI price translates into a disproportionate swing in earnings because lease operating expense, transportation and DD&A are largely fixed in the short run.

Gross profit and operating income line items are not available on a like-for-like basis from the available XBRL data, which prevents a clean ratio calculation across the income statement. What can be inferred is that depreciation, depletion and amortization of $1.847 billion in Q2 2026—broadly flat versus $1.823 billion in Q2 2025—is the dominant structural cost and reflects the capital intensity of the upstream book. Capital expenditures of $1.589 billion in the quarter reinforce that this is a high-reinvestment business; the available SEC data cannot separate maintenance from growth capital, and that limitation must be flagged rather than papered over. Inventories of $2.185 billion include $915 million of commodity oil carried at the lower of cost or net realizable value, exposing reported earnings to write-downs in a downside scenario. The principal observable condition that would weaken the profit engine is a sustained reversal in WTI back toward the $60s, because at that level gas realizations are already negative and the heavy DD&A burden would compress segment earnings quickly.

Earnings Quality and Cash Conversion

Where the issuer reports cash flow and capital expenditure cumulatively, the standalone-quarter cash-flow figures are derived by subtracting the preceding cumulative filing. They are calculations from SEC facts rather than separately reported quarterly line items.

Trailing twelve-month operating cash flow of $10.976 billion against trailing twelve-month net income of $7.311 billion implies strong cash conversion in aggregate, but the quarter-by-quarter pattern is noisy. Q2 2026 operating cash flow of $4.271 billion exceeded net income of $2.996 billion because the quarter benefited from a working-capital build and timing of collections; investors should not extrapolate that gap forward. Capital expenditures of $1.589 billion in Q2 2026 yielded an accounting free-cash-flow proxy of $2.682 billion for the quarter and roughly $4.793 billion on a trailing-twelve-month basis. Because the filings do not distinguish maintenance from growth capital, this proxy carries an explicit limitation: it cannot tell the reader how much of that cash flow is genuinely distributable versus how much is required to simply hold production flat.

The earnings quality picture is muddied by items the company itself flags as comparability distortions: $105 million in oil and gas derivative gains in Q2 2026, $178 million in midstream derivative gains, and a $220 million gain from a pro-rata ownership reduction in Western Midstream following the Brazos Delaware II acquisition. These are real cash items, but they are not part of the core recurring engine and should be modeled separately. The discontinuation of OxyChem removed what had been a substantial earnings contributor, so year-over-year comparisons across segments require care. The tax rate of 23 percent on continuing operations for Q2 2026 versus 39 percent in Q1 2026 is a useful signal: in a quarter with much higher pre-tax income, the effective rate compresses toward the U.S. federal statutory level, which suggests that the rate itself is income-mix driven rather than discretionary.

Business Quality, Moat, and Industry Position

On the available evidence, the company is best described as an important participant, not a demonstrated core supply-chain bottleneck. This classification describes strategic position only; it is not independent proof of a moat or valuation upside.

Occidental's competitive position rests on a portfolio of large, long-life upstream assets in the Permian Basin, the DJ Basin, the Gulf of America, Oman, Algeria and the UAE, combined with a midstream footprint that includes a 36.4 percent limited-partner interest in Western Midstream Partners. The Permian position, in particular, has been built up through the 2024 CrownRock acquisition and prior Anadarko transactions, and the company describes itself as among the largest U.S. oil producers with leading positions in two of the most economic basins in North America. That scale, along with the midstream integration, is the principal source of structural advantage.

The moat, however, is fundamentally a commodity moat: it is real estate and infrastructure rather than brand, technology or contractual stickiness. Pricing power at the wellhead is essentially zero; Occidental sells into a global benchmark market and captures a small premium or discount relative to WTI or Brent depending on basin location and quality. The bottleneck evidence is mixed. Oil and gas acreage is a substitute-good industry with abundant global supply, but Occidental's low-cost Permian acreage and its integrated midstream capacity at Waha represent a real physical asset that competitors cannot easily replicate at scale. The same-date Waha hub reference in the filing underscores the locational value of being the lowest-cost mover from the most economic basin. A 0-5 scoring exercise assigns roughly a 2 to the bottleneck position: assets are material but largely commoditized, and competitive intensity from other large independents and majors remains meaningful.

Management cites expertise in enhanced oil recovery and CO2 utilization as a differentiated technical capability. That is observable in the Oxy Low Carbon Ventures direct air capture and CCUS activities, but the financial contribution of those activities to consolidated cash flow is not separately broken out and remains a data gap for an investor trying to size the long-term option value. Overall, the industry position is durable in the sense that the reserves will produce for decades, but durability of the cash flow itself is a direct function of the commodity cycle that management cannot control.

Management and Capital Allocation

The capital allocation record of the past twelve months is the most informative data point on management quality. The company sold OxyChem for $9.5 billion in cash, recognized a $3.1 billion gain, used after-tax proceeds plus operating cash to repay $8.6 billion of debt, and ended the quarter with $4.15 billion in cash and a debt structure dominated by long-dated fixed-rate instruments. Long-term debt fell from $20.623 billion at year-end 2025 to $13.540 billion at June 30, 2026, a 34 percent reduction in six months. That is decisive balance-sheet improvement and removes a meaningful portion of the historical leverage concern that had been attached to the Anadarko and CrownRock transactions.

Common and preferred dividends paid totaled $0.839 billion in the first half, with the preferred dividend of $340 million annually fixed by Berkshire Hathaway's preferred position. Share repurchases were modest at $117 million of treasury stock purchases, and $1.223 billion remained authorized under the 2023 buyback plan, indicating that management is still prioritizing debt reduction over aggressive return of capital. The current compensation structure ties executives through Cash Return on Capital Employed Incentive (CROCEI) and Total Shareholder Return Incentive (TSRI) awards, an alignment pattern that is broadly sensible for a capital-intensive cyclical. What cannot be verified from the available evidence is the integrity of decision-making on capital projects outside the public filings, and that remains a qualitative judgment. The CEO separation agreement disclosed in the exhibits—Vicki Hollub's separation effective June 1, 2026—introduces a leadership transition risk that has not yet been quantified in the numbers.

Valuation and What the Market Already Expects

The dated market capitalization of $54.834 billion at $55.13 per share on August 3, 2026 sits well below the trailing-twelve-month free-cash-flow yield would suggest on a naïve basis. With a trailing-twelve-month accounting free-cash-flow proxy of $4.793 billion, the cash-flow yield is roughly 8.7 percent on the equity market cap before any balance-sheet adjustment. However, the available base scenario uses $4.793 billion as the base free cash flow and asks what growth rate is required to justify the market cap: the reverse-DCF implied growth is negative 2.4 percent, indicating that the market is pricing the stock to deliver flat-to-declining cash flows from current levels rather than continued commodity tailwind.

Qualitatively, this means the market is not paying for an oil-price cycle peak; if anything, it is paying for a reversion toward a lower free-cash-flow base. The available base scenario applies first-half-of-decade free cash flow growth and a 3 percent terminal growth assumption at a 9 percent discount rate, producing a fair market cap meaningfully above the current price. The dated market price therefore embeds a more conservative operating outlook than the company's reported results would suggest, but a reader should not interpret that as automatic cheapness. The inventory exposure to lower oil prices, the recent leadership transition, and the gas-realization weakness all qualify the bullish case.

Ten-Year Cash Flow to Fair Market Value

The starting free cash flow is the normalized SEC cash-flow proxy, while every growth rate, discount rate and terminal rate below is an explicit editorial assumption rather than company guidance. Each annual cash flow is forecast and discounted separately; terminal value is year-ten free cash flow multiplied by one plus terminal growth, divided by discount rate minus terminal growth, and then discounted back ten years. Fair market capitalization equals that explicit ten-year present value plus discounted terminal value and a same-date balance-sheet adjustment when available. If current cash and debt facts do not share one report date, the table shows the adjustment as unavailable and conservatively applies zero. The share count is derived from the dated market capitalization and share price so US shares and foreign ADRs use a consistent traded-security denominator.

Year

Bear FCF

Base FCF

Bull FCF

1

$5.2B

$5.5B

$5.8B

2

$5.6B

$6.3B

$7.0B

3

$6.0B

$7.2B

$8.4B

4

$6.5B

$8.3B

$10.2B

5

$7.0B

$9.5B

$12.2B

6

$7.3B

$10.2B

$13.4B

7

$7.5B

$10.9B

$14.7B

8

$7.7B

$11.6B

$16.1B

9

$7.9B

$12.4B

$17.6B

10

$8.2B

$13.3B

$19.3B

Scenario

Growth years 1–5 / 6–10

Discount

Terminal

10-year PV

Terminal PV

Balance-sheet adjustment

Fair market cap

Fair value/share

Margin of safety

Terminal share

Bear

8.0% / 3.0%

11.0%

2.0%

$38.9B

$32.6B

N/A (treated as $0)

$71.5B

$71.85

23.3%

45.6%

Base

14.6% / 7.0%

9.0%

3.0%

$57.1B

$96.5B

N/A (treated as $0)

$153.7B

$154.50

64.3%

62.8%

Bull

20.6% / 9.5%

8.5%

3.5%

$75.2B

$176.7B

N/A (treated as $0)

$251.9B

$253.26

78.2%

70.1%

In the reverse-DCF, holding the 9% discount rate and 3% terminal growth fixed, and solving only for one constant growth rate rather than using the base-case growth path, the current market capitalization implies roughly -2.4% annual free cash flow growth for ten years. This is a sensitivity framework, not a price target: the terminal-value share shows how strongly each result depends on assumptions beyond the explicit forecast. Negative margin of safety means the current market capitalization exceeds the scenario value.

Five Value-Investing Lenses

Benjamin Graham Lens

The Graham test asks whether the common stock trades at a meaningful discount to a conservatively measured intrinsic value and whether the balance sheet can absorb a deep commodity downturn. Book value of stockholders' equity stood at $41.746 billion at quarter-end, so the dated market capitalization of $54.834 billion sits at roughly 1.3 times tangible book. Long-term debt of $13.540 billion is now well covered by cash plus expected operating cash flow, a notable improvement from the elevated leverage of the post-Anadarko years. The acid test in a Graham frame is normalized earnings power: trailing-twelve-month diluted EPS of $6.79 against a $55.13 price implies a trailing P/E near 8 times, but that figure embeds a favorable commodity window and should not be relied upon as a permanent valuation anchor. The current price offers some margin of safety against the valuation analysis scenarios, but Graham would demand a wider buffer against the volatility that oil prices can deliver.

Benjamin Franklin Lens

Franklin's lens, applied as a modern discipline of thrift and opportunity cost, asks whether management is converting today's windfall into permanent value rather than spending it. The answer on the evidence available is clearly yes: $8.6 billion of debt repaid in six months is precisely the disciplined response to a commodity windfall that a Franklin-style operator would advocate. The opportunity cost of holding excess cash at a cyclical producer, however, is non-trivial, and the modest $117 million of buybacks against $1.223 billion of authorization suggests that management is still being more conservative than the value-conscious shareholder might wish. Capital intensity remains high, with $3.143 billion of capital expenditures in the first half, and that reinvestment burden is the structural drag on compounding that Franklin would weigh carefully.

Warren Buffett Lens

Buffett's frame asks whether normalized owner earnings justify the enterprise value and whether management is allocating capital with a long-term owner's mindset. The available base free cash flow of $4.793 billion as the starting point, combined with the reduction in debt, is a step toward a cleaner owner-earnings calculation than the post-Anadarko balance sheet ever permitted. The $3.1 billion gain on the OxyChem sale was a one-time event that improved reported earnings but should not be capitalized into a multiple. Management's decision to focus on debt repayment rather than aggressive buybacks at the top of a price cycle is the kind of capital-allocation discipline Buffett typically praises. The remaining question is whether Occidental's resource base will generate normalized free cash flow materially above current levels once the commodity cycle normalizes, and on that point the available base and bull scenarios project meaningful improvement while the bear scenario does not.

Charlie Munger Lens

Munger would invert the thesis: what is the most likely way this investment permanently loses money? The most plausible answer is a multi-year period of oil prices below the company's breakeven, with high leverage amplifying losses, but that scenario is partially mitigated by the recent debt reduction. A second inversion question asks what management incentive could distort judgment; the CROCEI and TSRI compensation plans are reasonably aligned but still reward short-term capital efficiency metrics that could encourage underinvestment in maintenance during a downturn. A third inversion looks at opportunity cost: even if Occidental's intrinsic value is well above the current price, an investor must compare that return against other cyclical or non-cyclical alternatives available at similar valuations, and the available evidence does not permit that comparison.

Li Lu Lens

Li Lu would frame the question through circle of competence, culture and permanent-loss control. The upstream oil and gas business is a cyclical commodity operation whose economics are well understood and within most investors' circle of competence, but the cultural and political risks of operating in Oman, Algeria, the UAE and the Gulf of America require ongoing monitoring. The dominant shareholder position of Berkshire Hathaway through preferred stock and warrants creates a governance dynamic that protects common shareholders to some degree but also concentrates influence. Permanent-loss control is the binding question: at current prices and with the balance sheet repair that has occurred, the downside in a worst-case oil-price scenario is more limited than it was twelve months ago, but the cash-flow yield still depends on commodity prices staying well above mid-cycle norms.

Risks, Disconfirming Evidence, and What Would Prove This Thesis Wrong

The first observable thesis breaker is a sustained decline in WTI below $60 per barrel combined with negative U.S. gas realizations, which would compress oil and gas segment earnings toward or below the levels seen in the first half of 2025 and reduce the free-cash-flow yield materially. The second thesis breaker is a material adverse change in Middle East operations, where the filing acknowledges that international sales volumes have been affected by conflict-related disruptions; an escalation that interrupts production would reduce the diversification benefit of the international portfolio. The third thesis breaker is leadership and governance risk introduced by the CEO separation effective June 1, 2026, which has not yet been quantified and could affect the strategic direction of the company.

Disconfirming evidence already in the filing includes the negative U.S. natural gas realizations of ($1.48) per Mcf in Q2 2026, the modest share-repurchase activity despite a stated authorization, and the $238 million and $263 million of common dividends paid during the first half that represent a real cash drain even at the reduced debt level. The most likely wrong assumption in any bullish thesis is that the recent commodity tailwind represents a permanent shift rather than a cyclical move, and that the cash conversion seen in Q2 2026 will persist into 2027 and beyond. The opportunity cost of holding this stock at a single-digit P/E versus other cyclicals at similar valuations is also relevant and is not addressed by the available evidence.

Investment Conclusion

At the dated market capitalization of $54.834 billion on August 3, 2026, Occidental offers a free-cash-flow yield in the high single digits and a balance sheet that has been substantially repaired by the OxyChem proceeds. The valuation analysis scenarios consistently place the implied fair market capitalization above the dated price, with the bear scenario alone offering a margin of safety above 20 percent and the base scenario offering a meaningfully wider cushion. The qualitative signal from the reverse-DCF calculation—that the market is pricing in modestly negative free-cash-flow growth—is consistent with a stock that is being valued as a cyclical rather than as a permanent earnings platform. On the available evidence, the conclusion is that Occidental is worth watching as a cyclical cash-flow idea at a discount, with the caveat that valuation discipline, not operational execution, is the binding constraint and that mid-cycle commodity assumptions drive the upside.

This article is for research and educational purposes and does not constitute personalized investment advice.

Share this article

FacebookX

4 sources

Sources